Open an Account
search icon
2
NOTIFICATIONS
Best Algo trading app in India
Bigul

PARNAX LAB LTD. - 506128 - Announcement under Regulation 30 (LODR)-Appointment of Statutory Auditor/s

 Dear Sir, Pursuant to the provisions of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) 2015 we wish to inform you that the Board of Directors of the Company at its meeting held today i.e., Saturday, 14th August, 2021, which commenced at 5.00 p.m. and concluded at 5.50 p.m. at its Registered Office, had consider, in compliance with rotational requirements of Statutory Auditors of the Company as per Section 139 of Companies Act, 2013 and after reviewing recommendations of the Audit Committee, granted in-principle approval to appointment of M/s. C N Patel & Co., Chartered Accountants, Mumbai as Statutory Auditors of the Company in place of retiring auditors M/ s Ladha Singhal & Associates, Chartered Accountants, to hold office from the expiry of current term of retiring auditors at the ensuing general meeting till the conclusion of general meeting to be held in 2026.
14-08-2021
Bigul

PARNAX LAB LTD. - 506128 - Financial Results For Quarter Ended 30-06-2021.

 Dear Sir, Kindly find enclosed herewith the following: 1. A Copy of Standalone & Consolidated Un-Audited Financial results with Limited Review Report of the Company for the quarter ended 30th June 2021; Kindly take on your record and acknowledge receipt of the same.
14-08-2021
Bigul

Parnax Lab Ltd - 506128 - Board Meeting Outcome for Outcome Of Board Meeting

 Outcome of Board Meeting held on 14th August, 2021
14-08-2021
Bigul

PARNAX LAB LTD. - 506128 - Board Meeting Intimation for Approval Of Un-Audited Standalone And Consolidated Financial Results For The Quarter Ended June 30, 2021.

 PARNAX LAB LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2021 ,inter alia, to consider and approve Standalone and Consolidated Un-audited IND-AS compliant Financial Results along with Limited Review Report for the quarter ended 30th June, 2021 pursuant to regulation 33 of Listing Obligation and Disclosure Requirement, 2015. 2. Any other business with permission of Chair and with the consent of a majority of the Directors present in the Meeting including include at least one Independent Director. The approved results will be sent to you after conclusion of Board meeting. Kindly acknowledge the receipt of the same.
06-08-2021
Bigul

PARNAX LAB LTD. - 506128 - Shareholding for the Period Ended June 30, 2021

 Parnax Lab Ltd has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2021. For more details, kindly Click here
19-07-2021
Bigul

Parnax Lab Ltd - 506128 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Dear Sir, Pursuant to the provisions of Regulation 74(5) or Securities and Exchange Board of India (Depositories and Participants) Regulation, 2018, Please find enclosed herewith Compliance Certificate received from the Link Intime India Private Limited, Registrar and Share Transfer Agent (RTA) of our Company for the quarter ended 30th June, 2021. You are requested to take the same on record.
14-07-2021
Bigul

PARNAX LAB LTD. - 506128 - Statement Of Investor Complaints For The Quarter Ended June 2021

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Preet Vijay KukrejaDesignation :- Company Secretary and Compliance Officer
10-07-2021
Bigul

Parnax Lab Ltd - 506128 - Closure of Trading Window

 Dear Sir/Madam, Pursuant to BSE Circulars dated 2nd April, 2019 vide Ref No: LIST/COMP/01/2019-20 please note that the Trading Window for dealing in the securities of the Company shall remain closed for all Designated Persons with effect from 01st July, 2021 for the purpose of consideration of Unaudited Financial result for the quarter ended 30th June, 2021. The Trading Window shall open 48 hours after the Unaudited Financial Result for the quarter ended 30th June, 2021 become generally available to the Public. The above is for your information and record. Kindly take the same on your record and oblige.
30-06-2021
Bigul

PARNAX LAB LTD. - 506128 - Results-Audited Financial Results For The Quarter And Year Ended March 31, 2021.

 Kindly find enclosed herewith the following: 1. A Copy of Standalone and Consolidated Audited Financial results for the quarter and year ended 31st March, 2021 along with Auditor Report thereon; 2. Declaration pursuant to Regulation 33(3)(d) as amended by the SEBI (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2015. Kindly take the above in your record.
30-06-2021
Bigul

PARNAX LAB LTD. - 506128 - Outcome Of Board Meeting

 Dear Sir, Pursuant to the provisions of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) we wish to inform you that in the meeting of the Board of Directors of the Company held on Wednesday, 30th June, 2021 at its Registered Office, the Board inter alia has transacted the following business: 1. Approval of Audited Standalone & Consolidated Financial Results as submitted by statutory auditor of the Company for the quarter and year ended 31st March, 2021. 2. Considered and took note of Limited Review Report for the quarter and year ended 31st March 2021. The Meeting was commenced at 5.00 p.m. and concluded at 9.40 p.m. Kindly take the same on your record.
30-06-2021
Next Page
Close

Let's Open Free Demat Account